The increased <i>in vitro</i> phagocytic activity of resKCs and recMφs against FITC-<i>E</i>. <i>coli</i> and the decreased TNF-α production by LPS-stimulated liver MNCs following... by Takuya Ishikiriyama (6735674)

<i>Fkbp5</i> DNA methylation decreases with age in mice. by Jonathan J. Sabbagh (626366)

Overview of OmpA structure and points of allelic variation as previously described [46]. by Chunyu Liao (4436998)

MnTBAP treatment reduces caloric intake in mice fed a HFD. by Jonathan R. Brestoff (799142)

Comparison of the lipid PI, IPC and PE species between WT and MF200.5, AmB1000.1 or AmB1000.1+MT. by Christopher Fernandez-Prada (3375029)

“…When required parent-ion scanning of m/z 295 for C19Δand accurate mass assisted distinctions between PE species with the same nominal mass (<a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005171#pntd.0005171.s006" target="_blank">S6 Fig</a> and <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005171#pntd.0005171.s011" target="_blank">S3 Table</a>). …”

Developmental regulation of the decrease in adhesion. by Marco Tarantola (102609)

Excessive LF4A kinase activity shortens cilia and decreases IFT. by Yu-Yang Jiang (7036916)

Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif by Wan Fu (3681799)

“…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”

Kinetic and equilibrium constants for binding of WT and mutant FVIII-C2 proteins to BO2C11. by Jasper C. Lin (685807)

“…^†These substitutions resulted in a k_d >4X that of WT-FVIII-C2 for BO2C11 or abrogated binding to BO2C11. …”

Homozygous deletion of <i>ERG251</i> results in decreased fitness at low initial cell density and increased fitness in the presence of low concentrations of FLC (≤1μg/ml). by Xin Zhou (54275)

Accumulation of ClpB3 but not ClpC chaperones increases when DXS activity or MEP pathway flux decrease. by Pablo Pulido (2185855)

Down-regulation of VCAN or THBS2 decreased the cell proliferation in A549 cells. by Tzu-Yang Weng (2938080)

Data_Sheet_1_Early decrease of ventilatory ratio after prone position ventilation may predict successful weaning in patients with acute respiratory distress syndrome: A retrospecti... by Zhichang Wang (2560528)

“…VR responders were defined as patients showing a decrease in VR of greater than or equal to 0.037 from the baseline to within 4 h after prone. …”

Hypoxia and Cobalt decrease AQP5 mRNA by down-regulating AQP5 transcription. by Jitesh D. Kawedia (384551)

Irbesartan Decreases ¹⁴C-FDG and ^99mTc-annexin A5 Accumulation Levels. by Yan Zhao (58882)

Subjects:

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Predicted distribution of boat sizes, given a 10 percentage point increase in the probability of interception. by Katherine Hoffmann Pham (11619125)

Increased BBB disruption, with a decrease in endothelial ZO-1, claudin-5 and occludin, avoided by GM6001. by Saran Feng (345936)

HealthRise patient shifts in disease severity categories between baseline and endline based on biometric readings for hypertension (A) and diabetes (B). by Nancy Fullman (243628)

Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A₁ ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in th... by Shouping Wang (402959)

“…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A₁ AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A₁ ARs. …”